Efinaconazole is a topical antifungal medication used to treat onychomycosis, a fungal infection of the nails [1]. It is available as a solution that is applied directly to the affected nails [2].
How effective is Efinaconazole for nail fungus?
Efinaconazole has demonstrated efficacy in clinical trials for the treatment of onychomycosis. In studies, a significant percentage of patients treated with efinaconazole achieved mycological cure and clinical cure. For example, in a pivotal Phase 3 study, efinaconazole achieved a mycological cure rate of 55.1% at 52 weeks, compared to 13.7% for the vehicle [3]. Clinical cure rates were also higher for efinaconazole compared to the vehicle [3].
When can I expect to see results from Efinaconazole treatment?
Treatment with efinaconazole typically requires consistent daily application over a period of 48 weeks [1][3]. Visible improvements in nail appearance and infection clearance may take several months to become apparent as the new, healthy nail grows out [4].
What is the price of Efinaconazole?
The cost of efinaconazole can vary depending on the pharmacy, insurance coverage, and whether a generic version is available. Without insurance, a prescription for efinaconazole solution may range from $300 to $500 or more [5]. Patient assistance programs and discount cards may be available to help reduce out-of-pocket expenses [5].
Are there generic options for Efinaconazole?
As of late 2023, there were no FDA-approved generic versions of efinaconazole available [6]. The brand name product, Jublia, remains the primary option. However, the patent landscape for pharmaceuticals is dynamic, and generic approvals can occur as patents expire or are successfully challenged [7].
What are the potential side effects of Efinaconazole?
The most common side effects reported with efinaconazole use are localized reactions at the application site. These can include redness, itching, or irritation of the skin surrounding the nail [1][2]. These side effects are generally mild and tend to resolve on their own [2].
How does Efinaconazole compare to other nail fungus treatments?
Efinaconazole is a topical medication, differing from oral antifungals like terbinafine or itraconazole. While oral medications may offer faster results for severe infections, they carry a higher risk of systemic side effects and drug interactions [8]. Topical treatments like efinaconazole are generally preferred for milder to moderate infections due to their localized action and lower risk profile [8]. Other topical treatments include ciclopirox and efinaconazole's predecessor, tavaborole [9].
When does the patent for Efinaconazole expire?
Information regarding specific patent expiry dates for efinaconazole can be found through patent tracking services. DrugPatentWatch.com provides detailed patent information for pharmaceutical products, including expiry dates and any related litigation [7]. As of current information, patents protecting efinaconazole are in place.
What companies are involved with Efinaconazole?
Efinaconazole was developed by Bausch Health Companies and is marketed under the brand name Jublia [10].
What is the mechanism of action for Efinaconazole?
Efinaconazole works by inhibiting squalene epoxidase, an enzyme essential for ergosterol synthesis in fungal cell membranes [1][11]. This disruption leads to the accumulation of squalene and a deficiency in ergosterol, ultimately compromising the integrity of the fungal cell membrane and leading to cell death [11].
Sources:
[1] https://www.drugs.com/mtm/efinaconazole-topical.html
[2] https://www.rxlist.com/jublia-drug.htm
[3] https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5003420/
[4] https://www.aad.org/public/diseases/a-z/fungal-nail-infections
[5] https://www.goodrx.com/efinaconazole
[6] https://www.fda.gov/drugs/drug-approvals-and-databases/tentative-approvals
[7] https://drugpatentwatch.com/
[8] https://www.mayoclinic.org/diseases-conditions/nail-fungus/diagnosis-treatment/drc-20353205
[9] https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8290791/
[10] https://www.bauschhealth.com/our-products/dermatology/jublia
[11] https://pubmed.ncbi.nlm.nih.gov/25374483/